Publications by authors named "Yunus Catma"

Objective: Hyperinflammation (HI) that develops in week 2 of COVID-19 contributes to a worse outcome. Because week 2 laboratory findings can be relatively mild, the available criteria for classification of hemophagocytic lymphohistiocytosis or macrophage activation syndrome are not helpful.

Methods: Our study included a discovery cohort of patients from Turkey with symptomatic COVID-19 who were followed up while hospitalized during the initial wave and a replication cohort of hospitalized patients from a later period, all of whom required oxygen support and received glucocorticoids.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to compare the clinical characteristics and outcomes of hospitalized patients diagnosed with COVID-19 based on PCR test results, focusing specifically on older adults.
  • A total of 601 hospitalized adults were analyzed, revealing that both PCR-positive and negative patients had similar demographics, hospitalization durations, and outcomes, with a few notable differences in symptoms.
  • The findings suggest that PCR-positive and negative cases show similar disease patterns, but PCR-negative patients may have a weaker immune response, indicated by some worse laboratory results.
View Article and Find Full Text PDF

Background: While there are substantial reports on the acute phase of Covid-19, the data on post-Covid phase are limited.

Aim: To report the data on older post-Covid patients comparatively with the young adults.

Study Design: Retrospective, single-center study in post-Covid outpatient clinic.

View Article and Find Full Text PDF

Myocardial injury caused by COVID-19 was reported in hospitalized patients previously. But the information about cardiac consequences of COVID-19 after recovery is limited. The aim of the study was comprehensive echocardiography assessment of right ventricular (RV) in patients recovered from COVID-19.

View Article and Find Full Text PDF

Background: The novel coronavirus infection (COVID-19) disease has spread rapidly and posed a great threat to global public health. The laboratory parameters and clinical outcomes of the disease in discharged patients remain unknown. In this study, we aimed to investigate the laboratory and echocardiographic findings of patients with COVID-19 after discharge and the relation between left ventricular global longitudinal strain (LVGLS) and inflammatory parameters in discharged patients.

View Article and Find Full Text PDF

Background: The information on electrocardiographic features of patients with coronavirus disease 2019 (COVID-19) is limited. Our aim was to determine if baseline electrocardiographic features of hospitalized COVID-19 patients are associated with markers of myocardial injury and clinical outcomes.

Methods: In this retrospective, single center cohort study, we included 223 hospitalized patients with laboratory-confirmed COVID-19.

View Article and Find Full Text PDF

Thrombotic and embolic complications in the cardiovascular system are evident and associated with worse prognosis in coronavirus disease 2019 (COVID-19) patients. Endothelial-specific molecule 1 (endocan) plays a role in vascular pathology. We hypothesized serum endocan levels on admission are associated with primary composite end point (mortality and intensive care unit hospitalization) in COVID-19 patients.

View Article and Find Full Text PDF

Introduction: COVID-19 caused by the SARS-CoV-2 continues to spread rapidly across the world. In our study, we aim to investigate the relationship between the liver enzymes on admission (AST, ALT, ALP, GGT) and severity of COVID-19. We evaluated course of disease, hospital stay, liver damage and mortality.

View Article and Find Full Text PDF

BACKGROUND Cytomegalovirus (CMV) and BK virus (BKV) are post-transplant opportunistic viral infections that affect patient and graft survival. This study was designed to evaluate the risk of BKV nephropathy and CMV disease in kidney transplant recipients who received induction therapy with ATG or basiliximab. MATERIAL AND METHODS We retrospectively analyzed information on 257 adult patients who underwent kidney transplantation between January 2007 and 2017.

View Article and Find Full Text PDF